ATG5 and Miyoshi myopathy: To further confirm the role of autophagy in TRIM44-mediated effects, we knocked down ATG5 in TRIM44 overexpressing (TRIM44[OE]) MM cells and control (TRIM44[CON-OE]) MM cells using siRNAs, followed by Bortezomib treatment.